Researchers at the Johns Hopkins Bloomberg School of Public Health conducted an analysis of worldwide use of Haemophilus influenza Type b vaccine (Hib) to determine what factors influenced a nation's adoption of the vaccine. The study found that a nation ...
Source:
Johns Hopkins University Bloomberg School of Public Health
Monday, March 15, 2010